Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial.
Ni L, Wen Z, Hu X, Tang W, Wang H, Zhou L, Wu L, Wang H, Xu C, Xu X, Xiao Z, Li Z, Li C, Liu Y, Duan J, Chen C, Li D, Zhang R, Li J, Yi Y, Huang W, Chen Y, Zhao J, Zuo J, Weng J, Jiang H, Wang DW.
Ni L, et al. Among authors: zhou l.
Front Med. 2021 Oct;15(5):704-717. doi: 10.1007/s11684-021-0853-6. Epub 2021 Apr 28.
Front Med. 2021.
PMID: 33909260
Free PMC article.
Clinical Trial.